IP Library Assignment 015233/0181
Patent Assignment
Reel/Frame 015233/0181

Confirmatory Licenses for Government Register

Recorded: 2004-04-22 Pages: 6
Assignor
KAYLONE BIOPHARMACEUTICALS
Executed: 2003-12-22
Assignee
UNITED STATES GOVERNMENT SECRETARY OF THE ARMY, THE
504 SCOTT STREET, ARMY MEDICAL RESEARCH ARD MATERIEL, FORT DETRICK, MARYLAND, 21702
Covered Properties (4)
Compositions and Methods for the Diagnosis, Treatment and Prevention of Steroid Hormone Responsive Cancers
Patent: 7,947,463 →
Application: 09/852,547 →
Publication: US 2002/0006630
Compositions and Methods for Demonstrating Secretory Immune System Regulation of Steroid Hormone Responsive Cancer Cell Growth
Patent: 7,947,275 →
Application: 09/852,958 →
Publication: US 2002/0012954
Anti-Estrogen and Immune Modulator Combinations for Treating Breast Cancer
Patent: 8,119,138 →
Application: 10/293,439 →
Publication: US 2003/0072760
Screening Method for Predicting Susceptibility to Breast Cancer
Patent: 7,863,011 →
Application: 10/293,440 →
Publication: US 2003/0059433
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2002
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 012731/0072 →
Assignment of Assignor's Interest Mar 18, 2002
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 012731/0181 →
Assignment of Assignor's Interest Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEM, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013737/0963 →
Assignment of Assignor's Interest Feb 10, 2003
From: UNIVERSITY OF TEXAS SYSTEMS, THE
To: SIRBASKU, DAVID A.
Reel/Frame 013737/0951 →
Assignment of Assignor's Interest Feb 19, 2007
From: SIRBASKU, DAVID A., PHD
To: SIGNE BIOPHARMA INC.
Reel/Frame 018902/0870 →
Change of Assignee Address Sep 5, 2007
From: SIGNE BIOPHARMA INC.
To: SIGNE BIOPHARMA INC.
Reel/Frame 019785/0099 →
Assignment of Assignor's Interest Jan 30, 2012
From: SIRBASKU, DAVID A
To: SIGNE BIOPHARMA INC.
Reel/Frame 027618/0021 →
Assignment of Assignor's Interest Jan 30, 2012
From: SIRBASKU, DAVID A
To: SIGNE BIOPHARMA INC.
Reel/Frame 027617/0906 →